Senior Editor, Diagnostic Imaging
Clarity Pharmaceuticals to Begin Phase 3 Trial for New PSMA PET Agent for Prostate Cancer
July 5th 2023The prospective multicenter trial, which is slated to begin patient recruitment in late 2023, will reportedly assess the ability of 64Cu SAR-bisPSMA to diagnose prostate cancer within pelvic lymph nodes.
Icometrix Gets First CPT III Code Issued by AMA for AI Brain MRI Software
July 3rd 2023Reportedly receiving the first Current Procedural Terminology (CPT) III code from the American Medical Association (AMA) for artificial intelligence (AI)-enabled brain magnetic resonance imaging (MRI) software, Icometrix says its adjunctive quantification software can be utilized for diagnosis and assessment of conditions ranging from Alzheimer’s disease and epilepsy to stroke and dementia.
Study: Photon-Counting CT for Pulmonary Angiography Allows Significant ICM Reduction
July 3rd 2023New research suggests the use of high-pitch photon-counting computed tomography (PCCT) facilitates similar image quality and attenuation in the pulmonary trunk at lower iodinated contrast media (ICM) dosing levels ranging from 35 to 60 ml.
Hybrid PET/MRI Assessment with Hippocampal Radiomics May Facilitate Early Alzheimer's Diagnosis
June 30th 2023Employing a hybrid positron emission tomography (PET)/magnetic resonance imaging (MRI) model to assess predictive features of Alzheimer’s disease (AD), researchers noted a 100 percent sensitivity rate and a 93 percent sensitivity rate for distinguishing between AD and normal cognition, according to a study presented at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Chicago.
New Research Shows Viability of PET Imaging Agent for Clear Cell Renal Cell Carcinoma
June 29th 2023In an interview at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Chicago, Jeremie Calais, M.D., MSc discussed promising research findings for the use of the positron emission tomography (PET) imaging agent 89ZR-DFO-girentuximab for diagnosing clear cell renal cell carcinoma.
Can Molecular Imaging Provide Key Insights on Obesity Interventions?
June 28th 2023New research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference suggests that neuroreceptor differences in reactions to visual food cues between obese people and normal-weight individuals may improve the understanding of underlying mechanisms that contribute to obesity.
A Closer Look at Urinary Activity and PET Radiopharmaceuticals for Prostate Cancer Imaging
June 28th 2023In a recent interview at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Chicago, Phillip Kuo, M.D., Ph.D, F.A.C.R., discussed the potential impact of urinary activity with positron emission tomography (PET) radiopharmaceuticals, and new phase 3 study data that found low urinary activity with the use of the flotufolastat F 18 injectable agent in patients with prostate cancer.
Molecularly Targeted Radiation Agent Facilitates Bone Marrow Transplant in Acute Myeloid Leukemia
June 27th 2023The research, which garnered “Abstract of the Year” honors at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Chicago, demonstrates the potential of the targeted agent to significantly improve survival rates in AML.
Ultravist Becomes First FDA-Approved Contrast Agent for Contrast-Enhanced Mammography
June 24th 2023Ultravist is reportedly the first contrast agent to gain a specific indication for visualization of known or suspected lesions on contrast-enhanced mammography, which was recently recommended by the American College of Radiology as a supplemental imaging alternative to magnetic resonance imaging (MRI) in women with dense breasts at the age of 40 and other risk factors for breast cancer.
Philips Set to Showcase Ultrasound Compact 5500CV at ASE Conference
June 22nd 2023The new portable ultrasound device, which is being showcased at the American Society of Echocardiography (ASE) conference, offers enhanced cardiac imaging as well as shared transducer interoperability and workflows with existing EPIQ CVx and Affiniti CVx ultrasound systems.
Deep Learning Network Shows Significant Potential for Prostate Cancer Detection on MRI
June 22nd 2023In multiple datasets from a study involving reviewed data from over 2,700 bi-parametric magnetic resonance imaging (MRI) scans, a deep neural network demonstrated area under the receiver operating characteristic (AUROC) scores ranging from 87 to 89 percent for the detection of clinically significant prostate cancer.
FDA Clears Image Processing Software with Emphasis on Nuclear Medicine Imaging Workflow
June 21st 2023The InterView Fusion and InterView XP reportedly improve image quality for single-photon emission computed tomography (SPECT) and offer imaging tools specifically geared to common nuclear medicine studies ranging from bone imaging to cardiac assessment and lung imaging.
Study Examines Photon-Counting CT for CAD Detection in Patients Having TAVR Procedures
June 20th 2023In a study cohort of patients undergoing pre-operative workup for transcatheter aortic valve replacement (TAVR), researchers found the use of photon-counting CT for ultra-high resolution coronary CT angiography had a 96 percent sensitivity rate and an 84 percent specificity rate for the detection of coronary artery disease (CAD).
Deep Learning Detection of Mammography Abnormalities: What a New Study Reveals
June 19th 2023In multiple mammography datasets with the original radiologist-detected abnormality removed, deep learning detection of breast cancer had an average area under the curve (AUC) of 87 percent and an accuracy rate of 83 percent, according to research presented at the recent Society for Imaging Informatics in Medicine (SIIM) conference.
Expediting the Management of Incidental Pulmonary Emboli on CT
June 16th 2023In a recent video interview from the Society for Imaging Informatics in Medicine (SIIM) conference, Ali Tejani, M.D., discussed pertinent insights on leveraging the value of adjunctive artificial intelligence (AI)-enabled triage software for computed tomography (CT) scans with radiology workflow improvements to achieve “clinically meaningful change” for patients with incidental pulmonary emboli findings.
Study Says AI Mapping More Effective than MRI for Assessing Extent of Prostate Cancer
June 15th 2023Combining multimodal imaging data and biopsy data, an artificial intelligence (AI) model provided enhanced sensitivity for defining prostate cancer tumor margins in comparison to conventional magnetic resonance imaging (MRI) assessments.
Radiology Challenges with Breast Cancer Screening in Women with Breast Implants
June 14th 2023In a recent video interview, Stephen Rose, M.D., reviewed a variety of factors that can impact interpretation of breast imaging for women with breast implants and discussed recent research showing a 22 percent reduction in cancer detection rate for this population in comparison to women without breast implants.
PSMA PET Imaging May Offer Key Prognostic Markers for Prostate Cancer
June 12th 2023For patients initially diagnosed with non-metastatic, castration-resistant prostate cancer, pelvic lymph node involvement and five or more polymetastases detected with prostate-specific membrane antigen (PSMA)/ positron emission tomography (PET) are significantly associated with lower overall survival rates, according to recently presented research at the American Society of Clinical Oncology (ASCO) conference.
Could Gamification Enhance Brain MRI Acquisition?
June 9th 2023FIRMM-pix, a brain magnetic resonance imaging (MRI) software module recently launched at the International Society for Magnetic Resonance in Medicine (ISMRM) conference, reportedly employs visual biofeedback and gamification that coaches patients to stay still during brain MRI exams.
Stress Cardiovascular MRI: What a New Meta-Analysis Reveals
June 8th 2023For the detection of obstructive coronary artery disease (CAD), stress cardiovascular magnetic resonance imaging (MRI) demonstrated a sensitivity rate of 81 percent and a specificity rate of 86 percent, according to a meta-analysis of 64 studies and data from 74,470 patients with stable chest pain.
Study Assesses Ability of Mammography AI Algorithms to Predict Breast Cancer Risk
June 7th 2023Five artificial intelligence (AI) algorithms for mammography assessment were better at predicting breast cancer risk over five years than the Breast Cancer Surveillance Consortium (BCSC) risk model, according to new retrospective research involving over 13,000 women.
What a Large CT Study Reveals About Potential Kidney Injury, Diabetes and Risk Stratification
June 7th 2023The use of contrast-enhanced computed tomography (CECT) was associated with more than double the risk of contrast-induced acute kidney injury (CI-AKI) in patients with diabetes and an estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m2 in comparison to the use of non-contrast CT in this population.
New System Combines Diagnostic Ultrasound and Transient Elastography
June 6th 2023In order to facilitate optimal detection and assessment of liver fibrosis and steatosis, the newly launched Hepatus 6 Diagnostic Ultrasound System offers the capabilities of real-time two-dimensional ultrasound with visual transient elastography in one device.